Biolight Life Sciences Ltd
TASE:BOLT
Biolight Life Sciences Ltd
Cash from Operating Activities
Biolight Life Sciences Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Cash from Operating Activities
-₪9.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
Compugen Ltd
NASDAQ:CGEN
|
Cash from Operating Activities
-$32.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-18%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Cash from Operating Activities
-$7.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
See Also
What is Biolight Life Sciences Ltd's Cash from Operating Activities?
Cash from Operating Activities
-9.6m
ILS
Based on the financial report for Dec 31, 2023, Biolight Life Sciences Ltd's Cash from Operating Activities amounts to -9.6m ILS.
What is Biolight Life Sciences Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
Over the last year, the Cash from Operating Activities growth was -1%. The average annual Cash from Operating Activities growth rates for Biolight Life Sciences Ltd have been 6% over the past three years , 16% over the past five years , and 10% over the past ten years .